Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2013 Sep 11;12(4):583–588.e1. doi: 10.1016/j.cgh.2013.08.043

Table 1.

Baseline Characteristics of subjects

BE/No OSA
(N=36)
BE/OSA
(N=74)
No BE/OSA
(N=78)
No BE/No OSA
(N=74)
p-value
Mean(SD) Age (y) 58(13) 64(11) 64(12) 57(17) *
Male gender, N (%) 25(69%) 58(78%) 56(72%) 52(70%) *
Mean(SD) BMI 30(5) 33(8) 32(6) 31(7) *
Caucasian race, N (%) 32/32(100%) 70/72(97%) 76/77(99%) 70/71(99%) 0.91
GERD on acid-suppression medication, N (%) 21(58%) 56(76%) 39(50%) 32(43%) <0.001
Smoking History, N (%) 23/36(64%) 54/73(74%) 51/76(78%) 44/74(59%) 0.31
*

Subjects matched on age, gender and BMI at time of polysomnogram